Welcome to our dedicated page for Under Armour SEC filings (Ticker: UA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Under Armour, Inc. Class C Common Stock (UA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. Under Armour, incorporated in Maryland and headquartered in Baltimore, files under Commission File Number 001-33202 and reports its financial results in accordance with U.S. GAAP, often accompanied by non-GAAP metrics such as "adjusted" and "currency neutral" figures.
For UA, Form 8-K filings are particularly relevant for tracking material events. Recent 8-Ks describe an expanded fiscal 2025 restructuring plan, including the Board-approved increase in expected restructuring and related charges, the inclusion of the Curry Brand separation, and the anticipated timing of completion. Other 8-Ks cover quarterly financial results, scheduled earnings conference calls, and significant executive changes, such as the planned appointment of a new Executive Vice President and Chief Financial Officer and the transition of the current CFO to a senior advisor role, as well as the departure of the Chief Product Officer and his subsequent advisory arrangement.
Through this filings page, users can review how Under Armour discloses costs associated with exit or disposal activities, restructuring charges, transformation expenses, and capital structure actions. The company’s filings also include extensive forward-looking statements and risk factor discussions that outline potential impacts from economic conditions, tariffs, competition, supply chain costs, global expansion, technology systems, access to capital, foreign currency, data security, public health emergencies, and litigation or other proceedings.
Stock Titan enhances these filings with AI-powered summaries that highlight the main points of each document, helping readers quickly understand the significance of new 8-Ks, annual and quarterly reports, and other submissions. Real-time updates from EDGAR, combined with simplified explanations of complex disclosures such as restructuring plans, executive compensation arrangements, and debt offerings, allow investors to analyze Under Armour’s regulatory history and ongoing obligations more efficiently.
Gibbs David W reported acquisition or exercise transactions in this Form 4 filing.
Under Armour director David W. Gibbs received a grant of 5,133.93 shares of Class C Common Stock on April 1, 2026 as compensation, not through an open-market purchase. The award represents director fees deferred as deferred stock units under Under Armour’s Fiscal Year 2025 Non-Employee Director Compensation Plan.
Following the grant, Gibbs directly holds 173,055.67 Class C shares. He also has indirect ownership of 50,000 Class C shares through the SJG Irrevocable Trust, providing additional exposure to Under Armour’s stock separate from his direct holdings.
Whitesell Patrick reported acquisition or exercise transactions in this Form 4 filing.
Under Armour, Inc. director Patrick Whitesell received a grant of 4,464.2900 shares of Class C Common Stock on April 1, 2026. The award represents director fees deferred as deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan and carried a stated price of $0.0000 per share. Following this grant, Whitesell directly holds 122,683.4300 shares of Class C Common Stock.
Under Armour, Inc. director Robert John Sweeney reported an acquisition of 4,910.7100 shares of Class C Common Stock. These shares were received at a stated price of $0.0000 per share as a grant or award of deferred stock units under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. After this award, Sweeney directly holds 180,340.6700 shares of Class C Common Stock.
Under Armour, Inc. director Dawn N. Fitzpatrick received an equity grant of 4,910.71 shares of Class C Common Stock as part of her board compensation. The shares were issued as deferred stock units under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan and carried no cash exercise price. Following this award, she directly holds a total of 180,340.67 Class C shares.
Under Armour director Carolyn Everson acquired additional equity-based compensation through deferred stock units. On April 1, 2026, she received 892.86 shares of Class C Common Stock at $0.00 per share as director fees deferred under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan. Following this grant, she directly holds 108,431.14 Class C shares, reflecting routine non-employee director compensation rather than an open-market purchase or sale.
El-Erian Mohamed reported acquisition or exercise transactions in this Form 4 filing.
Under Armour, Inc. director Mohamed El-Erian received a grant of 11,830.36 shares of Class C Common Stock as deferred stock units. The grant represents director fees deferred under the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.
After this award, he holds 224,011.67 shares of Class C Common Stock and 111,650 shares of Class A Common Stock directly. This transaction reflects compensation in stock units rather than an open-market purchase or sale.
Under Armour, Inc. director Douglas E. Coltharp reported an equity award of Class C Common Stock deferred stock units. On April 1, 2026, he received 6,361.6100 Class C shares at a stated price of $0.00 per share, representing director fees deferred under the company’s Fiscal Year 2025 Non-Employee Director Compensation Plan.
After this grant, Coltharp holds 317,690.4700 Class C shares directly, along with additional direct and indirect holdings of both Class C and Class A shares through personal accounts and family trusts. The filing reflects a compensation-related acquisition rather than an open-market trade.
The Vanguard Group filed Amendment No. 12 to Schedule 13G/A reporting zero beneficial ownership of Under Armour Inc. common stock as of the amendment. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, after which certain Vanguard subsidiaries report ownership separately and Vanguard no longer is deemed to beneficially own those securities.
The form lists 0 shares beneficially owned, 0% of the class, and zero voting and dispositive power. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
The Vanguard Group filed Amendment No. 16 to a Schedule 13G/A reporting 0 shares beneficially owned of Under Armour Inc. (Common Stock). The amendment explains an internal realignment on January 12, 2026 and states certain subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538. The filing lists Amount beneficially owned: 0 and Percent of class: 0%. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Under Armour, Inc. Form 144 notice reports proposed sales of multiple lots of Class A and Class C common stock that were acquired as restricted stock units. The filing lists individual lots with acquisition dates from 02/15/2015 through 02/15/2021